| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,120 |
19,222 |
$852K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,983 |
7,113 |
$425K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,461 |
2,053 |
$147K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,066 |
1,989 |
$133K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,900 |
2,668 |
$95K |
| W0037 |
|
6,903 |
6,903 |
$79K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
717 |
670 |
$73K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
943 |
892 |
$59K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,571 |
3,367 |
$52K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,300 |
5,955 |
$51K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
516 |
473 |
$49K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
472 |
443 |
$31K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
479 |
450 |
$31K |
| 36415 |
Collection of venous blood by venipuncture |
5,101 |
4,380 |
$23K |
| 0240U |
|
171 |
167 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,650 |
2,373 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
854 |
743 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
632 |
552 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
585 |
248 |
$8K |
| 90671 |
|
288 |
285 |
$8K |
| 90474 |
|
1,080 |
1,004 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
179 |
159 |
$8K |
| 87634 |
|
126 |
118 |
$8K |
| 99215 |
Prolong outpt/office vis |
60 |
58 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
323 |
306 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
559 |
516 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
134 |
130 |
$4K |
| 90686 |
|
1,862 |
1,798 |
$4K |
| 81001 |
|
1,390 |
1,213 |
$4K |
| 0001A |
|
114 |
102 |
$4K |
| 0002A |
|
97 |
96 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
126 |
115 |
$3K |
| 90651 |
|
422 |
392 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
333 |
252 |
$3K |
| 0072A |
|
65 |
64 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
80 |
80 |
$3K |
| 0071A |
|
65 |
63 |
$2K |
| 91322 |
|
17 |
17 |
$2K |
| 90670 |
|
1,467 |
1,390 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
27 |
26 |
$2K |
| 99460 |
|
29 |
24 |
$2K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
30 |
25 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$1K |
| 90656 |
|
278 |
272 |
$1K |
| 90480 |
|
38 |
38 |
$1K |
| 99188 |
|
41 |
40 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
914 |
816 |
$926.35 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
30 |
29 |
$634.38 |
| 0004A |
|
21 |
14 |
$555.38 |
| 74018 |
|
31 |
27 |
$494.75 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
12 |
12 |
$392.37 |
| 99307 |
|
29 |
26 |
$376.76 |
| 90715 |
|
196 |
181 |
$256.24 |
| 96380 |
|
12 |
12 |
$238.20 |
| 80047 |
|
16 |
14 |
$191.06 |
| 90734 |
|
300 |
277 |
$118.70 |
| 90685 |
|
190 |
176 |
$101.75 |
| 86308 |
|
12 |
12 |
$85.22 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
15 |
12 |
$56.00 |
| 90696 |
|
155 |
139 |
$50.51 |
| 90697 |
|
163 |
160 |
$0.00 |
| 90680 |
|
1,118 |
1,062 |
$0.00 |
| 90723 |
|
1,017 |
952 |
$0.00 |
| 90716 |
|
89 |
85 |
$0.00 |
| 90648 |
|
49 |
48 |
$0.00 |
| 90633 |
|
115 |
112 |
$0.00 |
| 90707 |
|
85 |
82 |
$0.00 |
| 96160 |
|
27 |
24 |
$0.00 |